Document Detail

Propafenone--a new agent for the treatment of ventricular arrhythmias.
MedLine Citation:
PMID:  2679087     Owner:  NLM     Status:  MEDLINE    
Over the last several years a number of new and potent antiarrhythmic agents have been developed. One of these promising new drugs, propafenone hydrochloride (Rhythmol), will soon be available for use in this country. Although similar in some aspects to flecainide and encainide, the drug possesses some unique characteristics. The purpose of this review is to summarize the pharmacologic and physiologic effects of propafenone and to outline its clinical use.
B P Grubb
Related Documents :
11858397 - Torsade de pointes induced by metoclopramide in an elderly woman with preexisting compl...
10874257 - Classification and pharmacology of antiarrhythmic drugs.
2039027 - Moricizine: a new agent for the treatment of ventricular arrhythmias.
15534787 - Preclinical strategies to assess qt liability and torsadogenic potential of new drugs: ...
7808787 - Chronotherapy of cancer: biological basis and clinical application.
3534817 - Prescription drug abuse.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The American journal of the medical sciences     Volume:  298     ISSN:  0002-9629     ISO Abbreviation:  Am. J. Med. Sci.     Publication Date:  1989 Oct 
Date Detail:
Created Date:  1989-11-17     Completed Date:  1989-11-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370506     Medline TA:  Am J Med Sci     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  249-51     Citation Subset:  AIM; IM    
Department of Medicine, Medical College of Ohio, Toledo 43699.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arrhythmias, Cardiac / drug therapy*
Propafenone / adverse effects,  pharmacokinetics,  therapeutic use*
Ventricular Fibrillation / drug therapy
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Risk factors in early life as predictors of adult heart disease: the Bogalusa Heart Study.
Next Document:  Autosomal recessive form of connatal Pelizaeus-Merzbacher disease.